Market Tracker

12/19 4:48am ET

Dyax Corp (NASDAQ:DYAX)

15.05
Data as of Dec 18
 +0.53 / +3.65%
Today’s Change
6.05
Today|||52-Week Range
15.23
+99.73%
Year-to-Date

Today’s Trading

Previous close14.52
Today’s open14.82
Day’s range-- - --
Volume1,296,865
Average volume (3 months)1,049,643
Market cap$2.0B
Dividend yield--
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+56.25%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book67.14

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.41+2.70%
ABCOAdvisory Board Co-2.26-4.40%
FGENFibroGen Inc+0.67+2.45%
INCRINC Research Holding...+0.65+2.73%
Data as of 12/18/2014

Financials

Next reporting dateFebruary 18, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts